Disorders of Lipoprotein Metabolism
📧 Sign up to get email alerts when something new happens for Disorders of Lipoprotein Metabolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects [Phase 1]
Phase 1 trial assessing safety and tolerability of higher doses of HRS-5346 in healthy subjects.
-
FDA approval · 2021-01-13FDA Approved: GEMFIBROZIL — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the original ANDA for Gemfibrozil from XLCare Pharmaceuticals, granting approval for a generic version of the lipid-lowering dr…
-
CLINICAL_TRIALS research · 2018-04-19Clinical Trial Update: Lipoprotein and Apolipoproteins With Metabolic Liver Diseases
A clinical trial update on lipoprotein and apolipoprotein involvement in metabolic liver diseases; the current status of the trial is not sp…